Relationship Between Age-Related Macular Degeneration--Associated Variants of Complement Factor H and LOC387715 With Coronary Artery Disease

Pulido, Jose S.; McConnell, Joseph P.; Lennon, Ryan J.; Bryant, Sandra C.; Peterson, Lisa M.; Berger, Peter B.; Somers, Virend; Highsmith, W. Edward
March 2007
Mayo Clinic Proceedings;Mar2007, Vol. 82 Issue 3, p301
Academic Journal
OBJECTIVE: To determine whether either of the gene variants associated with age-related macular degeneration is associated with coronary artery disease (CAD). PATIENTS AND METHODS: This study consisted of 493 patients who underwent clinically indicated coronary angiography between June 1, 1998, and January 1, 1999. The Y402H variant of the complement factor H (CFH) gene and the A69S variant of the LOC387715 gene locus were examined by restriction fragment length polymorphism. Multiple logistic regression models were used to assess the association of CFH and LOC gene variants with CAD. Covarlates with well-established associations with CAD were also evaluated. RESULTS: Seventy patients (14%) were homozygous for the histidine variant (HH) of CFH, 237 (48%) were heterozygous for the histidine variant (HY), and 186 (38%) were homozygous for the tyrosine variant (YY). Three hundred eight patients (62%) were homozygous for the alanine allele of L0C387715, 170 (34%) were heterozygous for Ala and Ser alleles, and 15 (3%) were homozygous for the serine variant. The overall association of the CFH genotype with CAD was not statistically significant (P=.08). However, some evidence (P=.046) suggested that CAD was Increased for the HH genotype compared to the homozygous wild-type YY genotype (odds ratio, 1.95; 95% confidence interval, 1.01-3.76). Male sex, hypertension, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and age were other variables that demonstrated significant associations with CAD. The overall effect of the LOC genotype was not statistically significant (P=.06). Heterozygosity for the serine variant was (P=.02) associated with the absence of CAD vs the AS genotype (odds ratio, 0.59; confidence interval, 0.38-0.91; P=.02). CONCLUSION: The CFH genotype may have an independent association with CAD, although our evidence did not show statistical significance. Controlling for known risk factors, the age-related macular degeneration-associated HH variant appears to be associated with CAD. The L0C387715 gene may also play a role in CAD.


Related Articles

  • Research Briefs.  // Geriatrics;Jul2007, Vol. 62 Issue 7, p3 

    The article presents a summary of reports related to geriatrics published in various medical journals. They include "Withdrawal of Fall-Risk-Increasing Drugs in Older Persons: Effect on Tilt-Table Test Outcomes," "Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related...

  • Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. A A Fawzi // British Journal of Ophthalmology;Dec2009, Vol. 93 Issue 12, p1606 

    AIMS: To describe previously unreported retinal findings in patients with Alport Syndrome (AS), as well as review the range of ophthalmic manifestations. METHODS: Retrospective review of clinical records of patients with AS. RESULTS: Nine patients with AS were identified, of whom three had no...

  • Cognitive Impairment a Marker of AMD.  // Review of Optometry;6/15/2009, Vol. 146 Issue 6, p6 

    The article presents the study conducted by the researchers regarding association between cognitive impairment and age-related macular degeneration (AMD) in the U.S. The study which examined the Cardiovascular Health Study participants aims to determine if the impairment marks the development of...

  • SMOKE GETS IN YOUR EYES.  // Good Housekeeping;Mar2008, Vol. 246 Issue 3, p41 

    The article reports on a study in Australia which showed that cigarette smoking quadruples the chances of developing age-related macular degeneration. Macular degeneration is the leading cause of blindness in people over 55. The researchers also discovered that former smokers are also at...

  • Regular aspirin use linked with macular degeneration.  // Reactions Weekly;2/2/2013, Issue 1437, p3 

    The article discusses a research study which showed the association of regular aspirin use with age-related macular degeneration (AMD). Findings revealed the cumulative incidence of neovascular AMD among regular aspirin users compared with non-regular aspirin users. Several limitations of the...

  • Is Age-Related Macular Degeneration Associated with Stroke Among Elderly Americans? Duanping Liao; Jingping Mo; Yinkang Duan; Klein, Ronald; Scott, Ingrid U.; Huang, Kui A.; Haibo Zhou // Open Ophthalmology Journal;2008, Vol. 2, p37 

    Objective: To investigate whether age-related macular degeneration (AMD) is associated with the development of ischemic and hemorrhagic stroke among elderly Americans Design: Population-based cohort study. Participants: The five percent random sample of 2000-2003 Medicare enrollees was obtained....

  • THE FUTURE OF AMD THERAPY: COMBINATION THERAPY AND BEYOND.  // Review of Ophthalmology;Dec2004, Vol. 11 Issue 12, p34 

    The article presents the views of physicians related to the future prospects of Age-related Macular Therapy. Donald D'Amico opines that once these drugs are approved, the combination of Retaane and an intravitreal anti-VEGF agent will be a logical combination. Patients will be given Retaane...

  • Fruit That's Plum Good for Health and Taste. Schepers, Anastasia // Environmental Nutrition;May2006, Vol. 29 Issue 5, p8 

    The article discusses the therapeutic benefits of plums. The Chinese used smoked plums to quell nausea, reduce fevers and quiet coughs. Plums are used to remove tumors since 25 B.C. The high phenolic content in the fruit makes it an antioxidant. It can also offer protection against age-related...

  • Emerging Treatment Approaches for Neovascular Age-Related Macular Degeneration. Blumenkranz, Mark S. // Ophthalmology Times;6/1/2004 Supplement 5, Vol. 29, p11 

    Reports on treatment approaches for neovascular age-related macular degeneration. Evaluation of photodynamic therapy; Consideration of thermal coagulation as a better approach than pharmacologic therapy; Challenge of the regulatory approval of newer drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics